Moberg Analytics today announced the launch of its flagship Moberg Clinical Platform (MCP), the first product designed to handle both the complexity of the brain and the dynamic nature of brain injury. The system will be showcased at the Annual Meeting of the Neurocritical Care Society (NCS), September 17–21, in Montreal.

The Moberg Clinical Platform brings advanced analytics and AI to critical care, offering clinicians new insights into brain function that can directly inform patient management. Unlike traditional monitoring solutions, MCP is purpose-built to integrate multimodal data, analyse brain dynamics in near real time, and support clinicians in making timely, life-saving decisions.

Early customer feedback has been strongly positive. The platform is already deployed at three pilot sites in the U.S. and Europe, with additional hospitals and research centres in various stages of implementation. This momentum underscores the urgent need for more sophisticated tools in neurocritical care and reflects the platform's potential to transform practice at scale.

Currently used for research purposes, MCP is on track for regulatory clearance in mid-2026. In the meantime, its unveiling at the NCS Annual Meeting will provide clinicians, researchers, and industry leaders with their first opportunity to experience a system that redefines what's possible in brain monitoring and care.

Dick Moberg, CEO & Founder, Moberg Analytics, said, "Every ICU patient is connected to monitors for the heart and lungs, yet the brain—the organ most susceptible to costly complications in critical care—is rarely monitored with the same priority. It's time we monitor the brain as routinely as the heart and lungs."